Categories: News

CordovaCann (CSE: CDVA / OTCQB: LVRLF) to Present at Emerging Growth Conference on March 17, 2021

TORONTO, ON / ACCESSWIRE / March 15, 2021 / CordovaCann Corp. (CSE:CDVA)(OTCQB:LVRLF) (“Cordova” or the “Company”), a cannabis-focused consumer products company, is pleased to announce that it has been invited to present at the Emerging Growth Conference this Wednesday, March 17, 2021.

CordovaCann will be presenting at 11:30 Eastern time for 30 minutes.

Mr. Taz Turner, CEO of Cordova will give a presentation and subsequently open the floor for questions. Please ask your questions during the event and Mr. Turner will do his best to get through as many of them as possible.

Interested investors may register for the presentation with this link:

https://attendee.gotowebinar.com/register/6904637667304920590?source=LVRLF

For those not able to join the event live, an archived webcast of the presentation will be made available on EmergingGrowth.com.

About CordovaCann Corp.

CordovaCann Corp. is a Canadian-domiciled company focused on building a leading, diversified cannabis products business across multiple jurisdictions including Canada and the United States. Cordova primarily provides services and investment capital to the retail, processing and production vertical markets of the cannabis industry.

Company Contact:

Taz Turner

Chief Executive Officer
taz@cordovacann.com
(917) 843-2169

SOURCE: CordovaCann Corp.

View source version on accesswire.com:
https://www.accesswire.com/635384/CordovaCann-CSE-CDVA-OTCQB-LVRLF-to-Present-at-Emerging-Growth-Conference-on-March-17-2021

Staff

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

3 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

6 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

6 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

6 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

6 hours ago